Applied DNA Sciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Applied DNA Sciences generated cash of -$13,711,397, which is less than the previous year. Cash used in financing activities reached the amount of $13,398,596 last year. Net change in cash is therefore -$720,705.
Cash Flow
| 2015 | -6.96M | -2.13M | 15.02M |
|---|---|---|---|
| 2016 | -9.89M | -779.76K | 7.84M |
| 2017 | -7.47M | -145.43K | 6.10M |
| 2018 | -6.91M | -266.00K | 5.88M |
| 2019 | -6.86M | -67.43K | 5.82M |
| 2020 | -11.14M | -1.06M | 19.43M |
| 2021 | -13.38M | -2.54M | 14.70M |
| 2022 | -8.97M | -489.55K | 18.12M |
| 2023 | -6.21M | -1.09M | 0 |
| 2024 | -13.71M | -407.90K | 13.39M |
APDN Cash Flow Statement (2015 â 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.90M | 15.21M | 6.55M | 7.78M | 558.98K | 1.65M | 2.95M | 4.47M | 7.31M | 1.39M |
Operating activities | ||||||||||
Net income | -7.08M | -9.94M | -8.27M | -14.27M | -13.02M | -8.63M | -11.69M | -12.85M | -12.17M | -11.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 696.42K | 1.36M | 1.29M | 844.43K | 285.73K | 390.42K | 547.79K | 633.32K | 706.49K | 490.64K |
Stock-based compensation expense | 572.29K | 1.03M | 2.51M | 1.66M | 1.00M | 1.12M | 0 | 3.25M | 2.03M | 4.02M |
| Deferred income tax benefit | 572.29K | 1.03M | 2.51M | 1.66M | 1.00M | 1.12M | 0 | 3.25M | 2.03M | 4.02M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -106.51K | 3.05M | -532.95K | -2.63M | 600.35K | 638.33K | 1.08M | 3.08M | -2.59M | -4.63M |
Inventories | -108.56K | 272.21K | 767.68K | -872.56K | -354.73K | 78.74K | 105.09K | -28.70K | -297.75K | 30K |
Accounts payable | -480.44K | -1.35M | 930.49K | 125.12K | 400.07K | 691.66K | 158.00K | -777.95K | -237.12K | 1.16M |
Cash generated by operating activities | -13.71M | -6.21M | -8.97M | -13.38M | -11.14M | -6.86M | -6.91M | -7.47M | -9.89M | -6.96M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -407.90K | -1.14M | -489.55K | -2.54M | -1.06M | -67.43K | -266.00K | -145.43K | -785.26K | -638.56K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.5K | -1.5M |
Cash generated by investing activities | -407.90K | -1.09M | -489.55K | -2.54M | -1.06M | -67.43K | -266.00K | -145.43K | -779.76K | -2.13M |
Financing activities | ||||||||||
Common Stock Issued | 13.39M | 0 | 14.42M | 16.37M | 10.63M | 2.86M | 4.23M | 6.10M | 7.85M | 19.11M |
Payments for dividends | -233.08K | 0 | -110.10K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 952.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | -1.66M | -107.80K | 1.98M | -1.65M | 0 | 0 | 0 |
Cash used in financing activities | 13.39M | 0 | 18.12M | 14.70M | 19.43M | 5.82M | 5.88M | 6.10M | 7.84M | 15.02M |
Net Change In Cash | -720.70K | -7.31M | 8.66M | -1.23M | 7.22M | -1.10M | -1.30M | -1.51M | -2.83M | 5.91M |
Cash at end of period | 7.18M | 7.90M | 15.21M | 6.55M | 7.78M | 558.98K | 1.65M | 2.95M | 4.47M | 7.31M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |